Vulvodynia

A Rose by Any Other Name Still Has Thorns

This is the second article in a five-part series examining sexual pain and the physiologic, neurologic, and emotional systems involved in painful intimacy.

In the first article, sexual pain was introduced as more than a localized symptom. Pain alters anticipation, muscle tension, arousal, and behavior, gradually reshaping the relationship between intimacy and safety. That framework is essential to understanding vulvodynia, one of the most common and misunderstood sexual pain disorders.

This article focuses specifically on vulvodynia: what it is, why it develops, how it presents clinically, and why many patients struggle for years before receiving meaningful treatment.

What Is Vulvodynia?

The term vulvodynia simply means “pain in the vulva,” though the reality of the condition is considerably more complicated than the definition itself suggests. Vulvodynia is considered an umbrella diagnosis, one used to describe chronic vulvar pain in the absence of an immediately identifiable cause. According to the International Society for the Study of Vulvovaginal Disorders (ISSVD), vulvodynia is defined as vulvar pain lasting longer than three months without a clearly discoverable etiology.

This distinction is important because vulvodynia is descriptive rather than explanatory. In many ways, the diagnosis functions similarly to the phrase “headache.” It tells the clinician where the pain occurs, but not necessarily why it exists. Some patients ultimately prove to have specific etiologies; others exhibit patterns of centralized pain amplification in which the nervous system itself appears hypersensitized.

Vulvodynia is also extraordinarily common. Estimates suggest that approximately 16% of women worldwide experience vulvodynia at some point, with many cases occurring between the ages of twenty and forty. Despite this prevalence, underdiagnosis remains rampant, in part because many patients never disclose their symptoms, and in part because many clinicians receive little formal training in sexual pain evaluation.

Patients frequently arrive in clinic after years of uncertainty. Many have been repeatedly treated for presumed infections despite negative testing while others have been told their examinations are “normal,” leaving them feeling confused or invalidated by the absence of visible pathology. The invisibility of the condition often becomes one of its cruelest features. Patients are in pain, yet repeatedly encounter environments that subtly imply the pain should not exist.

Why Vulvodynia Develops

One of the greatest frustrations surrounding vulvodynia is that its exact cause remains incompletely understood. Current theories generally fall into two broad categories: those focused on localized tissue injury and those focused on abnormal nervous system processing. Increasingly, however, it appears that many patients exist somewhere between these extremes, with both peripheral and centralized mechanisms contributing simultaneously.

At the tissue level, repeated inflammation or irritation may sensitize local nociceptors over time. Chronic yeast infections, friction-related injury, or hormonal deprivation are frequently discussed as potential initiating events, while in peri- and postmenopausal patients, declining estrogen levels may thin vulvar and vestibular tissue, making it more vulnerable to irritation and microtrauma. Likewise, certain hormonal contraceptives may alter vestibular tissue quality in susceptible individuals, leaving pain long after the medication is discontinued.

Yet tissue alone does not fully explain vulvodynia. Many patients appear to develop a broader state of regional hypersensitivity in which the nervous system amplifies sensory input disproportionately. These individuals may also report urinary urgency or bowel symptoms, pelvic floor dysfunction, or other chronic pain conditions. In such cases, the issue is no longer confined to the vulvar tissue itself, but involves altered pain processing at multiple levels of the nervous system.

Over time, repeated painful experiences reinforce the association between touch and danger. Anticipation develops. Guarding develops. Hypervigilance develops. Eventually, even light contact that would ordinarily be interpreted as neutral may begin triggering pain responses. At that stage, vulvodynia has evolved beyond a simple inflammatory process and into a learned neurologic state shaped by neuroplasticity and reinforcement.

How Vulvodynia Presents Clinically

One of the defining characteristics of vulvodynia is variability. Some patients present with highly localized burning pain that occurs only during penetration, while others describe generalized discomfort present throughout the day regardless of activity. Pain may be provoked, spontaneous, or mixed. Some patients can identify a clear beginning to their symptoms, while others struggle to pinpoint when discomfort gradually became chronic.

The language patients use often provides important diagnostic clues. Burning, stinging, “electric,” or knife-like sensations frequently suggest neuropathic involvement, whereas dull or achy discomfort may point toward vascular or musculoskeletal contributors. Patients with vestibulodynia may report severe pain specifically at the vaginal opening during penetration, tampon insertion, or even prolonged sitting. Others may describe clitoral hypersensitivity severe enough that clothing itself becomes irritating.

Emotionally, vulvodynia can become profoundly destabilizing. Chronic genital pain occupies an intensely private and psychologically vulnerable space. Patients often fear intimacy, as worsening symptoms can lead to relationship strain, and even permanent loss of sexual function. Some report depression or anxiety as their chief complaint during medical visits, only later revealing that the source of distress is persistent vulvar pain.

Importantly, vulvodynia rarely exists in isolation from the broader sexual response cycle. As I’ve discussed before, pain alters arousal, lubrication, and muscular tension simultaneously. Patients may begin avoiding intimacy not because desire has disappeared, but because the nervous system has learned that intimacy predicts discomfort, and over time, this distinction becomes increasingly difficult for patients themselves to recognize, further complicating both diagnosis and treatment.

Evaluating the Patient With Vulvodynia

Evaluation of vulvodynia requires patience, structure, and precision. Because many patients have previously experienced dismissal or minimization, the clinical encounter itself can become therapeutic. Validation matters enormously. Simply hearing that the pain is real and deserving of investigation may represent the first meaningful intervention a patient has received in years.

A thorough sexual medicine examination is essential. The clinician should map the location, quality, and provocation pattern of pain carefully. For this, the Q-tip test remains one of the most useful tools for identifying focal vestibular tenderness, allowing the examiner to reproduce and localize pain systematically. Vulvoscopy may also be helpful, particularly when evaluating subtle erythema, dermatologic changes, or glandular abnormalities.

Attention should also be directed toward potential secondary contributors. Infection must be excluded when symptoms suggest vaginitis or other microbiologic pathology. Hormonal status should be considered, especially when vestibular tissue appears thin, erythematous, or fragile. Clitoral examination is equally important, as clitoral adhesions, keratin pearls, and even entrapped pubic hair may occasionally contribute to clitorodynia.

Perhaps most importantly, evaluation should extend beyond the vulva itself. Pelvic floor dysfunction commonly coexists with vulvodynia, either as a contributor to pain or as a secondary guarding response. Hypertonic pelvic floor musculature may dramatically amplify discomfort and perpetuate pain cycles. In many patients, successful treatment ultimately requires addressing both vulvar hypersensitivity and the muscular protective patterns that develop around it.

Treating Vulvodynia, and Why It Often Requires More Than One Therapy

There is no single universal treatment for vulvodynia because there is no single universal mechanism behind it. Effective treatment therefore tends to be multimodal, combining therapies aimed at tissue health, neural regulation, pelvic floor function, and emotional adaptation simultaneously. The goal is not simply suppressing symptoms, but reducing the nervous system’s expectation of pain.

For most patients, lifestyle modification is often an important starting point. Elimination of irritating soaps, detergents, restrictive clothing, or friction-provoking activities may significantly reduce symptom burden in some patients, and lubricants, topical lidocaine, and positional changes during intimacy may further improve comfort. These interventions are supportive rather than curative, but they help decrease repetitive nociceptive input that perpetuates sensitization.

Pelvic floor physical therapy remains one of the most valuable interventions available, particularly when muscular guarding or spasm is present. Likewise, cognitive behavioral therapy and sexual counseling may help patients address fear, catastrophization, and anticipatory anxiety surrounding intimacy. This is not because the pain is “psychological,” but because chronic pain inevitably affects emotional and neurologic processing simultaneously.

Yet perhaps the most important aspect of treatment is helping patients understand that pain with sex is neither imaginary nor inevitable. Vulvodynia is real. It is physiologic. And while treatment is often gradual and multifaceted, improvement is possible when the nervous system, tissue, and behavioral components of pain are addressed together.

© 2026 Corey R. Babb, DO, FACOOG, IF, MSCP. All rights reserved